Trademark: 98128436
Word
CHANTIBODY
Status
Pending
Status Code
641
Status Date
Wednesday, June 5, 2024
Serial Number
98128436
Mark Type
3
Filing Date
Friday, August 11, 2023

Trademark Owner History

Classifications
5 Biological preparations for the treatment of cancer, immunological-inflammatory and other chronic conditions; Biological products, namely, a drug delivery system comprising antibodies or antibody fragments which extend the effect of a wide variety of therapeutic agents, for medical use and for use in medical treatment; Biological products, namely, antibodies, antibody fragments for use in research and development of pharmaceuticals, manufacture of pharmaceuticals, and use of pharmaceuticals; Diagnostic preparations for medical purposes; Vaccines for human use; Therapeutic vaccines; Medical preparations, namely, antibodies, antibody fragments, for treatment of inflammatory, neoplastic, autoimmune, and cancer; Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; Pharmaceutical products, containing antibodies or antibody fragments for medical use and for use in medical treatment; Pharmaceutical preparations for the treatment and/or prophylaxis of chronic disease
The mark consists of the literal element "CHANTIBODY" in stylized font along with a radial three-loop design element in the upper right corner.
Color is not claimed as a feature of the mark.
The wording "CHANTIBODY" has no meaning in a foreign language.

Trademark Events
Aug 15, 2023
New Application Entered
Sep 11, 2023
New Application Office Supplied Data Entered
Sep 12, 2023
Notice Of Design Search Code E-Mailed
Apr 9, 2024
Assigned To Examiner
Jun 5, 2024
Non-Final Action Written
Jun 5, 2024
Non-Final Action E-Mailed
Jun 5, 2024
Notification Of Non-Final Action E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24